Products & Services · Net Sales
Hips — Net Sales
Stryker Hips — Net Sales decreased by 92.4% to $460M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 92.2%, from $5.87B to $460M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026May 11, 2026
Rolls up toTotal Revenue
How to read this metric
An increase indicates growing market share or higher procedure volumes in hip arthroplasty, while a decrease may signal increased competition, pricing pressure, or a slowdown in elective orthopedic surgeries.
Detailed definition
This metric represents the total revenue generated from the sale of hip reconstructive implants and related surgical ins...
Peer comparison
Comparable to hip implant revenue segments reported by major orthopedic competitors like Zimmer Biomet or DePuy Synthes.
Metric ID:
syk_segment_hips_net_salesHistorical Data
40 periods
| Q2 '21 | Q2 '21 | Q3 '21 | Q3 '21 | Q4 '21 | Q4 '21 | Q1 '22 | Q1 '22 | Q2 '22 | Q2 '22 | Q3 '22 | Q3 '22 | Q4 '22 | Q4 '22 | Q1 '23 | Q1 '23 | Q2 '23 | Q2 '23 | Q3 '23 | Q3 '23 | Q4 '23 | Q4 '23 | Q1 '24 | Q1 '24 | Q2 '24 | Q2 '24 | Q3 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q1 '25 | Q2 '25 | Q2 '25 | Q3 '25 | Q3 '25 | Q4 '25 | Q4 '25 | Q1 '26 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.29B | $353M | $4.16B | $328M | $4.7B | $352M | $4.28B | $327M | $4.49B | $364M | $4.48B | $347M | $5.2B | $375M | $4.78B | $375M | $5B | $393M | $4.91B | $362M | $5.82B | $414M | $5.24B | $393M | $5.42B | $428M | $5.49B | $420M | $6.44B | $463M | $5.87B | $443M | $6.02B | $466M | $6.06B | $457M | $7.17B | $499M | $6.02B | $460M |
| QoQ Change | — | -91.8% | >999% | -92.1% | >999% | -92.5% | >999% | -92.4% | >999% | -91.9% | >999% | -92.3% | >999% | -92.8% | >999% | -92.2% | >999% | -92.1% | >999% | -92.6% | >999% | -92.9% | >999% | -92.5% | >999% | -92.1% | >999% | -92.4% | >999% | -92.8% | >999% | -92.4% | >999% | -92.3% | >999% | -92.5% | >999% | -93.0% | >999% | -92.4% |
| YoY Change | — | — | — | — | — | — | — | — | +4.6% | -91.5% | +7.7% | -91.7% | +10.7% | -92.0% | +11.8% | -91.2% | +11.2% | -91.3% | +9.6% | -91.9% | +11.8% | -92.0% | +9.7% | -91.8% | +8.5% | -91.4% | +11.9% | -91.4% | +10.7% | -92.0% | +11.9% | -91.6% | +11.1% | -91.4% | +10.2% | -91.7% | +11.4% | -92.2% | +2.6% | -92.2% |
Range$327M – $7.17B
CAGR-20.5%
Avg YoY Growth-41.0%
Median YoY Growth-44.3%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's hips — net sales?
- Stryker (SYK) reported hips — net sales of $460M in Q1 2026.
- How has Stryker's hips — net sales changed year-over-year?
- Stryker's hips — net sales decreased by 92.2% year-over-year, from $5.87B to $460M.
- What does hips — net sales mean?
- The total revenue earned from selling hip replacement implants and associated surgical tools.